In the current concept of phototransduction, the concentration of cGMP in retinal rod outer segments is controlled by the balance of two enzyme activities: cGMP phosphodiesterase (PDE) and guanylyl cyclase (GC). However, no protein directly mediates these two enzyme systems. Here we show that RGS9, which is suggested to control PDE activity through regulation of transducin GTPase activity (He, W., Cowan, C. W., and Wensel, T. G. (1998) Neuron 20, 95-102), directly interacts with GC. When proteins in the Triton X-100-insoluble fraction of bovine rod outer segments were isolated by two-dimensional gel electrophoresis and binding of GC to these proteins was examined using a GC-specific antibody, proteins (55 and 32 kDa) were found to interact with GC. However, the activity of GC bound to the 55-kDa protein was not detected. This observation was elucidated by the finding that the 55-kDa protein inhibited GC activity in a dose-dependent manner. Amino acid sequence showed that five peptides derived from the 55-kDa protein were identical to corresponding peptides of RGS9. Together with other biochemical characterization of the 55-kDa protein, these observations indicate that the 55-kDa protein is RGS9 and that RGS9 inhibits GC. RGS9 may serve as a mediator between the PDE and GC systems.
In the prevailing model of phototransduction (1) (2) (3) , illuminated rhodopsin stimulates GTP/GDP exchange on T ␣ , 1 which in turn activates PDE through release or dislocation of P ␥ from P ␣␤ by GTP/T ␣ . The resulting decrease of cytoplasmic [cGMP] leads to closure of cGMP-gated channels and hyperpolarization of photoreceptor plasma membranes. The closure of channels also blocks Ca 2ϩ influx, whereas Ca 2ϩ efflux by Na ϩ /Ca 2ϩ exchangers continues. The resulting decline in free [Ca 2ϩ ] activates GC. With inactivation of GTP/T ␣ -activated PDE by GTP hydrolysis on T ␣ and return of P ␥ to P ␣␤ , the GC activation serves to restore [cGMP] to the dark level. It has never been reported that any protein directly mediates between the PDE system and the GC system.
Recent studies have shown that regulation of PDE for the restoration of [cGMP] to the dark level is really complicated. Kawamura and Murakami (4) have suggested a mechanism to regulate the lifetime of GTP/T ␣ -activated PDE. He et al. (5) have suggested that RGS9, a retina-specific member of RGS family, accelerates hydrolysis of GTP bound to T ␣ and that this acceleration may shorten the lifetime of GTP/T ␣ -activated PDE. Phosphorylation by cyclin-dependent protein kinase 5 of P ␥ complexed with GTP/T ␣ may also be involved in the regulation of lifetime of GTP/T ␣ -activated PDE. 2 This phosphorylation could account for the turn-off of visual excitation without GTP hydrolysis that has been observed in vivo (6 -8) . We have also suggested that PDE is involved to increase cytoplasmic [cGMP] to the dark level by release of cGMP from noncatalytic sites on P ␣␤ in amphibian photoreceptors (9) .
As we suggested in our initial study about GC (10), the regulatory mechanism of GC is also complicated. Activation of GC by Ca 2ϩ /GCAPs has been established (11-13); however, a protein inhibitor on GC activity has also been isolated from amphibian photoreceptors (14) . Moreover, GC isoforms (10, (15) (16) (17) (18) as well as GC phosphorylation (19, 20) have been described, although the physiological significance of this GC diversity is unknown. We have expected that GC is also regulated by cytoskeletal proteins. In this study, we isolated GC-binding proteins (GCBPs) from a Triton X-100-insoluble fraction of bovine ROS. Partial amino acid sequences indicate that one of the GCBPs, GCBP-55, is identical to RGS9. Purification and characterization of GCBP-55 (RGS9) suggest that the protein interacts with GC and inhibits GC activity. We anticipate that GCBP-55 (RGS9) may control cytoplasmic [cGMP] through direct interaction with proteins involved in both the PDE and GC systems.
EXPERIMENTAL PROCEDURES
Materials-Chemicals used were obtained from the following sources: [␣- 32 P]GTP from NEN Life Science Products; Sephadex G-50 (super fine) and Pharmalyte from Amersham Pharmacia Biotech; adonitol, BHT, proteinase inhibitors, Nonidet P-40, Tween 20 and 40, and protein A-Sepharose beads from Sigma; Servalyte from Serva; Triton X-100 from Pierce; and Econo S columns (1 ml) from Bio-Rad. All proteins were prepared from dark-adapted frozen bovine retina obtained from Lawson Co. (Nebraska).
Purification of GC-Retinal GC was purified as described (10) . Using a Sephadex G-50 column (12 ϫ 40 mm), the buffer of GC preparation was changed to buffer A (20 mM Tris/HCl (pH 7.5), 1 mM DTT, 5 mM MgSO 4 , 0.2 mM PMSF, 0.0025% BHT, 100 mM KCl, 0.1% Tween 20). The active fraction was stored in 20% adonitol at Ϫ80°C until use.
Preparation of Triton X-100-insoluble Fraction-Washed ROS membranes were prepared from 100 retinas as described (10) . These membranes were solubilized with 20 ml of buffer B (5% Triton X-100, 20 mM Tris/HCl (pH 7.5), 1 mM DTT, 0.2 mM PMSF, 0.0025% BHT, 5 M aprotinin, 5 M leupeptin, 5 M pepstatin A). The insoluble fraction was spun down by centrifugation (100,000 ϫ g, 30 min, 4°C). The preparation is referred to as Triton X-100-insoluble fraction. Pellets were dissolved with the sample buffers for gel electrophoresis, and protein concentrations in the sample buffer were determined as described (10) .
Two-dimensional Gel Electrophoresis-Triton X-100-insoluble fraction (100 g of protein) was dissolved in 100 l of an isoelectrofocusing sample buffer (0.1% Nonidet P-40, 0.1% SDS, 400 mM acetic acid, 8.75 mM DTT), and then 100 mg of urea was added to the solution. Twodimensional gel electrophoresis was performed by the method of O'Farrell (21) with some modifications. Basic proteins were separated by the first dimensional gel (3 mm in diameter) containing 4% of Bio-Lyte (pH 6 -8) and 4% of Servalyte (pH 5-9). The sample was applied from the acidic side of gel. For the separation of acidic proteins, Pharmalyte (pH 3.5-9.5) was used, and the sample was applied from the basic side of the gel. Electrophoresis was carried out at 400 V for 14 h and then at 800 V for 2 h. The second dimensional electrophoresis was performed as described (10) .
GC Overlay Technique and GC Detection-After electrophoretic separation of proteins in the Triton X-100-insoluble fraction, proteins were blotted on PVDF membranes. Proteins on the membranes were stained with 0.1% (w/v) Coomassie Blue in methanol (30 s). Following washing with 10% acetic acid and 50% methanol, the protein profile was recorded. To denature proteins, membranes were then destained with methanol, rinsed five times with distilled water, and incubated for 30 min at room temperature in buffer C (50 mM Tris/HCl (pH 8.0), 5 mM 2-mercaptoethanol, 6 M guanidine-HCl). To renature proteins, membranes were incubated with buffer D (50 mM Tris/HCl (pH 8.0), 5 mM 2-mercaptoethanol, 0.05% Tween 40) for 40 min at 4°C three times. Membranes were then washed three times with buffer E (20 mM Tris/ HCl (pH 7.5), 100 mM KCl, 1 mM DTT, 5 mM MgSO 4 , 0.1% Tween 20, 0.2 mM PMSF, 0.0025% BHT) and incubated in 1 ml of the same buffer containing 0.3 g/ml of purified GC (overnight, 4°C). Membranes were washed with buffer E (5 min, three times). To detect GC bound to GCBPs using a GC-specific antibody, the GC-overlaid PVDF membrane (Bio-Rad, 0.2 m) was immersed in buffer F (25 mM Tris/HCl (pH 8.0), 137 mM NaCl, 2.7 mM KCl) containing 0.1% Triton X-100 and the GC-specific antibody (2 h, 4°C). Following extensive washing with buffer F (three times), immunodetection was performed by the ECL detection kit (Amersham Pharmacia Biotech). When GC bound to GCBPs was detected by GC activity, the membranes (Immobilon-P, Millipore) were cut into 3-mm strips along the electrophoresis direction. To measure GC activity, each strip was incubated in 100 l of buffer G (final concentration for GC assay, 5% dodecyl maltoside, 50 mM Tris/ HCl (pH 7.5), 1 mM DTT, 2 mM MnCl 2 ), and synthesis of cGMP was measured by incubating with a solution (final concentrations, 1 mM GTP, 1 mM cGMP, 1.0 Ci of [␣-32 P]GTP, and 0.1 Ci of [ 3 H] cGMP) at 35°C for 3 h. Synthesized cGMP was measured as described (10) .
Amino Acid Sequencing of the GCBP-55-The N-terminal amino acid sequence of GCBP-55 on a PVDF membrane (ProBlot, Applied Biosystems) was analyzed by a protein sequencer (Applied Biosystem 473 A). To determine the internal amino acid sequence, purified GCBP-55 was digested with CNBr or V8 protease as described (22) . Peptides were separated by the neutral pH SDS-polyacrylamide gel electrophoresis (23) and blotted on PVDF membranes. Each peptide was analyzed by a protein sequencer.
Antibody Preparation-A rabbit was immunized with a peptide corresponding to the N terminus of GCBP-55 (TIRHQGQQYRPRMAFLC) conjugated to key hole limpet hemocyanin. The antibody was purified using a peptide-conjugated column. The specificity of the GCBP-55 antibody has been confirmed by the observation that the antibody recognized only a 55-kDa protein in Triton X-100-insoluble fraction of bovine ROS (see Fig. 3 ) and also in ROS preparation (data not shown). The antibody for GC was prepared as described, and its specificity has been reported (24) .
Purification of GCBP-Anti-GCBP-55 antibody was immobilized on protein A-Sepharose beads as described (25) . Washed bovine ROS (30 mg protein) was solubilized with 30 ml of buffer H (50 mM Tris/HCl (pH 8.0), 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholic acid, 0.1% SDS) and centrifuged (100,000 ϫ g, 4°C, 1 h) . The supernatant was applied to an anti-GCBP-55 column (6 ϫ 10 mm). The flow-through fraction was also applied to the same column to ensure binding of all GCBP-55 to the column. The column was washed with 10 ml of buffer H and then 10 ml of buffer I (0.2% Triton X-100, 2 mM MnCl 2 , 1 mM DTT, 0.2 mM PMSF, 0.0025% BHT, 25% glycerol). GCBP-55 was eluted with buffer K (0.2% Triton X-100, 200 mM glycine/HCl (pH 2.8), 2 mM MnCl 2 , 1 mM DTT, 0.2 mM PMSF, 0.0025% BHT, 25% glycerol). Tris/HCl (pH 8.0, 1 M) was added immediately to neutralize the elute. GCBP-55 was further purified by an Eocono S column using a 0 -0.5 M NaCl gradient (5 column volumes) in a buffer containing 20 mM Tris/HCl (pH 7.5), 2 mM MnCl 2 , 1 mM DTT, 0.1% Triton X-100, 25% glycerol. The purity of GCBP-55 in each step of the purification is shown in Fig. 3 .
RESULTS AND DISCUSSION
Retinal GC has a single membrane-spanning domain that divides the protein into two roughly equal portions, an Nterminal extracellular domain and a C-terminal cytoplasmic domain (15) (16) (17) (18) . Solubilization of GC from bovine ROS membranes (10, 26) requires both high concentrations of salts, such as 1 M KCl, and nonionic detergents, such as Triton X-100, suggesting that GC binds to disk membranes through hydrophilic and hydrophobic interactions. We have speculated that GC may associate with cytoskeletal proteins through these interactions. Proteins in a Triton X-100-insoluble fraction of bovine ROS were separated by two-dimensional gel electrophoresis, and the proteins were blotted to PVDF membranes. Then purified GC was overlaid to these proteins, and GCBPs were identified using a GC-specific antibody. In the alkaline region, a single protein (55 kDa; pI, more than 8.0) bound to GC (Fig. 1B) . The protein (GCBP-55) was also recognized by Coo-
FIG. 1. Isolation and immunological detection of GCBPs in the
Triton X-100-insoluble fraction of bovine ROS. After proteins (100 g) of a Triton X-100-insoluble fraction were separated by two-dimensional gel electrophoresis, proteins were blotted to PVDF membranes, and these membranes were incubated with or without purified GC (0.3 g/ml) in buffer E (overnight, 4°C), and then GC bound to GCBPs were detected using an anti-GC antibody as described. A, B, and C, basic (pH 6 -9) proteins; D, E, and F, acidic (pH 4 -7) proteins. A and D, proteins stained with Coomassie Blue; B and E, GCBPs detected after overlay of purified GC to the membranes; C and F, membranes incubated without GC.
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massie Blue staining (Fig. 1A) . Purified GCBP-55, which is described below, was also detected in the same spot in the gels (data not shown). These observations indicate that a relatively large amount of GCBP-55 is present in bovine ROS. By comparing the immunoblot signal of GCBP-55 in ROS with those of known amounts of purified GCBP-55 on the same PVDF membranes, we estimate that 1 GCBP-55/1000ϳ2000 rhodopsin is present in bovine ROS. In the acidic region, two major signals around molecular mass 32 kDa (32-kDa GCBPs) and several minor signals (25, 20 , and 12 kDa) were found (Fig. 1E) . However, these GCBPs appear to be less abundant than GCBP-55 because these proteins were not detected by Coomassie Blue staining (Fig. 1D) . 32-kDa GCBPs may be different from GCAPs because of their different molecular mass. We note that only endogenous GC was detected if the GC overlay was omitted (Fig. 1, C and F) , indicating that the GC antibody used does not cross-react with all proteins except GC in ROS. Furthermore, it is noteworthy that purified GCBP-55 also revealed GC binding activity in GC overlay experiments (data not shown).
We also tried to detect these GCBPs by measuring the activity of GC bound to these proteins. After isolation of these GCBPs by SDS gel electrophoresis and blotting to PVDF membranes, the membranes were incubated with purified GC, and the activity of GC bound to GCBPs was measured. As shown in Fig. 2 , GCBPs with lower molecular mass were clearly detected; however, GCBP-55 was not detected by this method. These data suggested that GC bound to GCBP-55 is inhibited. Thus, we examined the effect of GCBP-55 on the activity of purified GC. As shown in Fig. 3 , GCBP-55 inhibited GC activity in a dose-dependent manner. Boiled GCBP-55 was inactive. We note that the inhibitory activity was coeluted with GCBP-55 from both the immunoaffinity and the ion exchange (Econo S) columns. GCBP-55 is not the GC inhibitor reported recently (14) , because amino acid sequences in these proteins are completely different, as described below.
We have analyzed the amino acid sequence of the N terminus of GCBP-55 and four peptides derived from purified GCBP-55 (Fig. 4) . A computer search indicates that all amino acid residues that we identified in five sequences were identical to the corresponding amino acid residues of RGS9 (5). These five sequences contain 125 amino acid residues (i.e. more than 25% of the amino acid sequence of RGS9). These data suggest that 
FIG. 2. Enzymographical observation of GCBPs in Triton
X-100-insoluble fraction. Proteins (50 g) of a Triton X-100-insoluble fraction was separated by SDS-polyacrylamide gel electrophoresis (8 -18%). After blotting to a PVDF membrane, the membrane was incubated with purified GC (0.3 g/ml) in buffer E (overnight, 4°C). Following washing, the membrane was cut into 3-mm strips. The activity of GC bound to GCBPs on these strips was measured. A, GC activity in these PVDF membrane strips. B, protein profile of Triton X-100-insoluble fractions. Proteins on the PVDF membrane were stained with Coomassie Blue. Arrowheads indicate the position of molecular mass standards. FIG. 3 . Inhibitory effect of GCBP-55 on GC activity. After purification of GCBP-55 by an anti-GCBP-55 antibody column, various amounts of GCBP-55 were incubated with purified GC (15 ng), and GC activity was measured as described. 100% of GC activity indicates 25 pmol of cGMP synthesized/min/tube. E, GC activity in the presence of 50 nM of boiled GCBP-55. Inset, GCBP-55 purity was also shown by SDS-polyacrylamide gel electrophoresis (8 -18%) and an anti-GCBPp55 antibody. 
Interaction of RGS9 with Guanylyl Cyclase 22171
GCBP-55 is identical to RGS9. RGS9 has been reported to be a member of RGS family, and the protein may be specific for photoreceptors. The following observations also support the idea that GCBP-55 and RGS9 are identical. (a) The molecular mass of GCBP-55 is similar to that of RGS9. The sequence of the bovine RGS9 open reading frame indicates that RGS9 is a 484-amino acid protein with a molecular mass of 56.7 kDa (5).
(b) The pI value of GCBP-55 was estimated to be more than 8.0 by two-dimensional gel electrophoresis (Fig. 1) . We note that under our conditions it is difficult to measure a pI value of more than 8.0. Calculation from the amino acid sequence indicates that the pI value of RGS9 is 9.54. (c) The localization of GCBP-55 has been shown in rod and cone photoreceptors in mammalian retinas by both light and electron microscopes (27) . RGS9 is also reported to be localized in ROS, although higher expression was observed in cone (5, 28) . (d) Both GCBP-55 and RGS9 are membrane-bound. Without detergent any buffer containing low salt (5 mM), moderate salt (100ϳ200 mM), or high salt (1-1.5 M) with or without GTP could not solubilize GCBP-55 (data not shown). Complete solubilization of GCBP-55 required a buffer containing Triton X-100 (2-5%) and KCl (1-1.5 M). We note that conditions required for the complete solubilization of GCBP-55 are the same conditions for the solubilization of GC (10, 26) . Although the GCBP-55 was observed in Triton X-100-insoluble fraction of ROS, approximately 40 -50% of total GCBP-55 was partially solubilized with 2% Triton X-100. This result was similar to the results reported by He et al. and others (5, 28) ; approximately 50% of RGS9 was solubilized by 30 mM octylglucoside. There are several questions in this study. (a) The KyteDoolittle hydrophilicity-plot clearly indicates that RGS9 is very hydrophilic. We cannot understand why GCBP-55 (RGS9) requires nonionic detergents for its solubilization. The simplest explanation might be that GCBP-55 (RGS9) is modified by lipid and binds tightly to a Triton X-100-insoluble protein(s) through hydrophobic interaction. However, neither any predicted transmembrane region nor sequence for isoprenylation and myristoylation sequence is present in RGS9. Palmitoylation seems to be unlikely (28) . We speculate that GC is a protein binding to RGS9 in the Triton X-100-insoluble fraction. (b) RGS9 has been proposed to be an activator for the hydrolysis of GTP on T ␣ , and the activation is accelerated by P ␥ (5). We do not know how membrane-bound RGS9 (GCBP-55) interacts with GTP-bound T ␣ in disk membranes, because T ␣ becomes soluble after GTP binding. We must confirm the acceleration of GTP hydrolysis by using RGS9 purified from bovine ROS. P ␥ did not stimulate the GCBP-55 inhibitory activity on GC activity (data not shown). (c) GC isoforms are present in ROS. GC used in this study appears to be a mixture of GC isomers. We do not know which GC is sensitive to GCBP-55 (RGS9). (d) The role of GC inhibitor is not clear in the prevailing model of phototransduction. In the current model, the basal GC activity is low, and the GC activity is increased by Ca 2ϩ -sensitive activators (GCAPs) when Ca 2ϩ concentration is decreased after hydrolysis of cGMP by PDE (1-3) . Thus, Ca 2ϩ is an indirect mediator between the PDE system and the GC system, and a GC inhibitor is not required. At present neither the effect of Ca 2ϩ nor the effect of GCAPs on the GCBP-dependent inhibition of GC activity is known. In this study we suggest that GCBP-55 (RGS9) directly interacts with GC and inhibits GC activity in a system reconstituted by purified proteins. Our observations suggest that GCBP-55 (RGS9) may function as a protein that mediates between the PDE system and the GC system.
